WHAT IS THE OPTIMAL THERAPEUTIC STRATEGY FOR LIMITED BRAIN METASTASES (BMS) FROM NON SMALL CELL LUNG CANCER (NSCLC)? PROGNOSTIC FACTORS CONDITIONING BRAIN CONTROL AND PATIENTS OUTCOME

导出原文传递

翻译打印收藏纠错

作者： Navarria, P. ^[1] ; Pessina, F. ^[2] ; Toschi, L. ^[1] ; Santoro, A. ^[1] ; Ascolese, A. ^[3] ; Clerici, E. ^[1] ; Franceschini, D. ^[1] ; Bello, L. ^[3] ; Scorsetti, M. ^[2]

作者单位： Humanitas Canc Ctr & Res Hosp, Radioterapy & Radiosurg Dept, Rozzano, Italy ^[1] Humanitas Canc Ctr & Res Hosp, Neurosurg Oncol Dept, Rozzano, Italy ^[2] Humanitas Canc Ctr & Res Hosp, Haematol & Oncol Dept, Rozzano, Italy ^[3]

发布时间 2017-11-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Neuro-oncology

2017年19卷May Suppl.3期

105-106页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

WHAT IS THE OPTIMAL THERAPEUTIC STRATEGY FOR LIMITED BRAIN METASTASES (BMS) FROM NON SMALL CELL LUNG CANCER (NSCLC)? PROGNOSTIC FACTORS CONDITIONING BRAIN CONTROL AND PATIENTS OUTCOME

Neuro-oncology

相似文献

Neuro-oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

WHAT IS THE OPTIMAL THERAPEUTIC STRATEGY FOR LIMITED BRAIN METASTASES (BMS) FROM NON SMALL CELL LUNG CANCER (NSCLC)? PROGNOSTIC FACTORS CONDITIONING BRAIN CONTROL AND PATIENTS OUTCOME

Neuro-oncology

相似文献

Neuro-oncology

相关期刊

检索历史清除